Summit X, LLC Neuronetics, Inc. Transaction History

Summit X, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$8.31 - $13.03 $1.7 Million - $2.66 Million	-204,202 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$13.6 - $19.58 $92,575 - $133,281	6,807 Added 3.45%	204,202 $104,000
Q2 2018 Sep 24, 2018	BUY	$26.61 - $27.78 $5.25 Million - $5.48 Million	197,395 New	197,395 $0

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $25.4M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.